𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Surgical and Biologic Outcomes After Neoadjuvant Bicalutamide Treatment in Prostate Cancer

✍ Scribed by Giovanni Luca Gravina; Claudio Festuccia; Giuseppe Paradiso Galatioto; Paola Muzi; Adriano Angelucci; Piero Ronchi; Alessia Mariagrazia Costa; Mauro Bologna; Carlo Vicentini

Book ID
116947569
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
302 KB
Volume
70
Category
Article
ISSN
0090-4295

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Bicalutamide dosages used in the treatme
Bicalutamide dosages used in the treatment of prostate cancer
✍ Kolvenbag, Geert J.C.M.; Nash, Anthony πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 200 KB πŸ‘ 2 views

## BACKGROUND. Androgen deprivation is often used for the treatment of patients with prostate cancer. Androgen deprivation can be achieved by surgical castration or medical castration, with or without using an antiandrogen. Each of these treatments may be used alone, or an antiandrogen may be used

Regressive changes and neuroendocrine di
Regressive changes and neuroendocrine differentiation in prostate cancer after neoadjuvant hormonal treatment
✍ Ahlgren, G.; Pedersen, K.; Lundberg, S.; Aus, G.; Hugosson, J.; Abrahamsson, P.- πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 260 KB πŸ‘ 1 views

## BACKGROUND. We studied the extent of neuroendocrine (NE) tumor cell differentiation and its relation to regressive changes in prostate cancer after 3-month hormonal treatment. METHODS. Radical prostatectomy specimens from 103 patients, randomized to 3-month neoadjuvant LH-RH-analogue treatment (